Impulse control disorders and compulsive behaviors associated with dopaminergic therapies in Parkinson disease

Howard D. Weiss, Laura Marsh

Research output: Contribution to journalArticle

Abstract

Impulse control disorders (ICD) (most commonly pathologic gambling, hypersexuality, and uncontrollable spending) and compulsive behaviors can be triggered by dopaminergic therapies in Parkinson disease (PD). ICD are especially prevalent in patients receiving a dopamine agonist as part of their treatment regimen for PD, and have also been reported when dopamine agonists are used for other indications (e.g., restless legs syndrome). Although these iatrogenic disorders are common, affecting 1 in 7 patients with PD on dopamine agonists, they often elude detection by the treating physician. ICD lead to serious consequences, causing significant financial loss and psychosocial morbidity for many patients and families. ICD can appear at any time during treatment with dopamine agonists, sometimes within the first few months, but most often after years of treatment, particularly when patients receive dopamine agonists and levodopa together. In most cases ICD resolve if the dopamine agonist is withdrawn, and PD motor symptoms are managed with levodopa monotherapy. Familiarity with the clinical aspects, risk factors, pathophysiology, and management of ICD is essential for physicians using dopaminergic therapies to treat PD and other disorders.

Original languageEnglish (US)
Pages (from-to)267-274
Number of pages8
JournalNeurology: Clinical Practice
Volume2
Issue number4
DOIs
StatePublished - Dec 2012
Externally publishedYes

Fingerprint

Disruptive, Impulse Control, and Conduct Disorders
Compulsive Behavior
Dopamine Agonists
Parkinson Disease
Levodopa
Therapeutics
Physicians
Restless Legs Syndrome
Gambling
Risk Management
Morbidity

ASJC Scopus subject areas

  • Clinical Neurology

Cite this

Impulse control disorders and compulsive behaviors associated with dopaminergic therapies in Parkinson disease. / Weiss, Howard D.; Marsh, Laura.

In: Neurology: Clinical Practice, Vol. 2, No. 4, 12.2012, p. 267-274.

Research output: Contribution to journalArticle

@article{b6d4fb07b2b44309865fdaaccb6f5cc9,
title = "Impulse control disorders and compulsive behaviors associated with dopaminergic therapies in Parkinson disease",
abstract = "Impulse control disorders (ICD) (most commonly pathologic gambling, hypersexuality, and uncontrollable spending) and compulsive behaviors can be triggered by dopaminergic therapies in Parkinson disease (PD). ICD are especially prevalent in patients receiving a dopamine agonist as part of their treatment regimen for PD, and have also been reported when dopamine agonists are used for other indications (e.g., restless legs syndrome). Although these iatrogenic disorders are common, affecting 1 in 7 patients with PD on dopamine agonists, they often elude detection by the treating physician. ICD lead to serious consequences, causing significant financial loss and psychosocial morbidity for many patients and families. ICD can appear at any time during treatment with dopamine agonists, sometimes within the first few months, but most often after years of treatment, particularly when patients receive dopamine agonists and levodopa together. In most cases ICD resolve if the dopamine agonist is withdrawn, and PD motor symptoms are managed with levodopa monotherapy. Familiarity with the clinical aspects, risk factors, pathophysiology, and management of ICD is essential for physicians using dopaminergic therapies to treat PD and other disorders.",
author = "Weiss, {Howard D.} and Laura Marsh",
year = "2012",
month = "12",
doi = "10.1212/CPJ.0b013e318278be9b",
language = "English (US)",
volume = "2",
pages = "267--274",
journal = "Neurology: Clinical Practice",
issn = "2163-0402",
publisher = "Lippincott Williams and Wilkins",
number = "4",

}

TY - JOUR

T1 - Impulse control disorders and compulsive behaviors associated with dopaminergic therapies in Parkinson disease

AU - Weiss, Howard D.

AU - Marsh, Laura

PY - 2012/12

Y1 - 2012/12

N2 - Impulse control disorders (ICD) (most commonly pathologic gambling, hypersexuality, and uncontrollable spending) and compulsive behaviors can be triggered by dopaminergic therapies in Parkinson disease (PD). ICD are especially prevalent in patients receiving a dopamine agonist as part of their treatment regimen for PD, and have also been reported when dopamine agonists are used for other indications (e.g., restless legs syndrome). Although these iatrogenic disorders are common, affecting 1 in 7 patients with PD on dopamine agonists, they often elude detection by the treating physician. ICD lead to serious consequences, causing significant financial loss and psychosocial morbidity for many patients and families. ICD can appear at any time during treatment with dopamine agonists, sometimes within the first few months, but most often after years of treatment, particularly when patients receive dopamine agonists and levodopa together. In most cases ICD resolve if the dopamine agonist is withdrawn, and PD motor symptoms are managed with levodopa monotherapy. Familiarity with the clinical aspects, risk factors, pathophysiology, and management of ICD is essential for physicians using dopaminergic therapies to treat PD and other disorders.

AB - Impulse control disorders (ICD) (most commonly pathologic gambling, hypersexuality, and uncontrollable spending) and compulsive behaviors can be triggered by dopaminergic therapies in Parkinson disease (PD). ICD are especially prevalent in patients receiving a dopamine agonist as part of their treatment regimen for PD, and have also been reported when dopamine agonists are used for other indications (e.g., restless legs syndrome). Although these iatrogenic disorders are common, affecting 1 in 7 patients with PD on dopamine agonists, they often elude detection by the treating physician. ICD lead to serious consequences, causing significant financial loss and psychosocial morbidity for many patients and families. ICD can appear at any time during treatment with dopamine agonists, sometimes within the first few months, but most often after years of treatment, particularly when patients receive dopamine agonists and levodopa together. In most cases ICD resolve if the dopamine agonist is withdrawn, and PD motor symptoms are managed with levodopa monotherapy. Familiarity with the clinical aspects, risk factors, pathophysiology, and management of ICD is essential for physicians using dopaminergic therapies to treat PD and other disorders.

UR - http://www.scopus.com/inward/record.url?scp=84875848859&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84875848859&partnerID=8YFLogxK

U2 - 10.1212/CPJ.0b013e318278be9b

DO - 10.1212/CPJ.0b013e318278be9b

M3 - Article

C2 - 23634371

AN - SCOPUS:84875848859

VL - 2

SP - 267

EP - 274

JO - Neurology: Clinical Practice

JF - Neurology: Clinical Practice

SN - 2163-0402

IS - 4

ER -